Annals of Diagnostic Pathology
Volume 12, Issue 1 , Pages 33-40 , February 2008

αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas

Some of the results were presented in poster format at the 95th Annual Meeting of the United States and Canadian Academy of Pathology, February 2006, Atlanta, GA.

  • Stephanie M. Sitterding, MD

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • William R. Wiseman, MD

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Carol L. Schiller, MD

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Chunyan Luan, MS

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Feng Chen, MD

      Affiliations

    • Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Jose V. Moyano, PhD

      Affiliations

    • Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • William G. Watkin, MD

      Affiliations

    • Evanston Northwestern Healthcare, Evanston, IL 60201, USA
  • ,
  • Elizabeth L. Wiley, MD

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
  • ,
  • Vincent L. Cryns, MD

      Affiliations

    • Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    • They have contributed equally and share senior authorship.
  • ,
  • Leslie K. Diaz, MD

      Affiliations

    • Department of Pathology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    • They have contributed equally and share senior authorship.
    • Corresponding Author InformationCorresponding author. Department of Pathology, Abbott Northwestern Hospital Laboratory, Minneapolis, MN 55407, USA.

References 

  1. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature. 2000;406:747–752
  2. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–10874
  3. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418–8423
  4. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–5374
  5. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502
  6. Abd El-Rehim D, Pinder S, Paish C, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004;203:661–671
  7. Putti TC, Abd El-Rehim DM, Rakha EA, et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005;18:26–35
  8. van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161:1991–1996
  9. Fulford LG, Easton DF, Reis-Filho JS. Specific morphological features predictive for the basal phenotype of grade 3 invasive ductal carcinoma of breast. Histopatholgy. 2006;49:22–34
  10. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19:264–271
  11. Tsuda H, Takarabe T, Hasegawa F, et al. Large, central acellular zones indicating myoepithelial differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol. 2000;24:197–202
  12. Rayson D, Adjei A, Suman V, et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol. 1999;10:413–419
  13. Khan H, Wyld L, Dunne B, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol. 2003;29:600–603
  14. Dunne B, Lee A, Pinder S, et al. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol. 2003;34:1009–1015
  15. Reis-Filho J, Milanezi F, Paredes J, et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2003;11:1–8
  16. Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic beast carcinomas are basal-like tumours. Mod Pathol. 2006;49:10–21
  17. Moyano JV, Evans JR, Chen F, et al. alphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest. 2006;116:261–270
  18. Parcellier A, Schmitt E, Brunet M, et al. Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Signal. 2005;7:404–413
  19. Takashi M, Katsuno S, Sakata T, et al. Different concentrations of two small stress proteins, alphaB-crystallin and HSP27 in human urological tumor tissues. Urol Res. 1998;26:395–399
  20. Mehlen P, Mehlen A, Guillet D, et al. Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J Cell Biochem. 1995;58:248–259
  21. Kamradt MC, Chen F, Cryns VL. The small heat shock protein alphaB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem. 2001;276:16059–16063
  22. Kamradt M, Chen F, Sam S, et al. The small heat shock protein alphaB-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem. 2002;277:38731–38736
  23. Mao Y, Liu J, Xiang H, et al. Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 2004;11:512–526
  24. Kamradt MC, Lu M, Werner ME, et al. The small heat shock protein alphaB-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem. 2005;280:11059–11066
  25. Aoyama A, Steiger RH, Frohli E, et al. Expression of alphaB-crystallin in human brain tumors. Int J Cancer. 1993;55:760–764
  26. Pinder S, Balsitis M, Ellis I, et al. The expression of alphaB-crystallin in epithelial tumors: a useful tumour marker?. J Pathol. 1994;174:209–215
  27. Chelouche-Lev D, Kluger HM, Berger AJ, et al. alphaB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer. 2004;100:2543–2548
  28. Diaz LK, Huo L, Gupta A, et al. Comparison of the effects of alcoholic formalin fixation to standard formalin fixation on estrogen receptor analysis by immunohistochemistry in beast cancer. In: Presented at the U.S. and Canadian Academy of Pathology (abstr 1462), Vancouver, British Columbia, Canada, March 6-12. 2004;
  29. Diaz LK, Gupta R, Kidwai N, et al. The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer. J Histochem Cytochem. 2004;52:501–507
  30. Donati V, Faviana P, Dell'omodarme M, et al. Applications of tissue microarray technology in immunohistochemisty: a study on c-kit expression in small cell lung cancer. Hum Pathol. 2004;35:1347–1352
  31. Packeisen J, Korsching E, Herbst H, et al. Demystefied…tissue microarray technology. Mod Pathol. 2003;4:198–204
  32. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol. 2001;6:2249–2256
  33. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;5:617–621
  34. Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol. 2003;27:82–90

PII: S1092-9134(07)00023-8

doi: 10.1016/j.anndiagpath.2007.02.004

Annals of Diagnostic Pathology
Volume 12, Issue 1 , Pages 33-40 , February 2008